M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)

NCT06509906 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Advanced Solid Tumor

Interventions

DRUG: M9466
DRUG: Irinotecan
DRUG: Folinic acid
DRUG: Fluorouracil (5-FU)
DRUG: Bevacizumab
DRUG: Granulocyte colony stimulating factor (G-CSF)

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

Merck KGaA, Darmstadt, Germany